nodes	percent_of_prediction	percent_of_DWPC	metapath
Pranlukast—ABCC2—Vincristine—muscle cancer	0.169	0.274	CbGbCtD
Pranlukast—ABCC2—Etoposide—muscle cancer	0.155	0.251	CbGbCtD
Pranlukast—ABCC2—Doxorubicin—muscle cancer	0.106	0.172	CbGbCtD
Pranlukast—ABCC2—Methotrexate—muscle cancer	0.102	0.166	CbGbCtD
Pranlukast—CYP3A4—Vincristine—muscle cancer	0.033	0.0536	CbGbCtD
Pranlukast—CYP3A4—Etoposide—muscle cancer	0.0303	0.0491	CbGbCtD
Pranlukast—CYP3A4—Doxorubicin—muscle cancer	0.0206	0.0335	CbGbCtD
Pranlukast—IL5—Cytokines and Inflammatory Response—CSF3—muscle cancer	0.0167	0.0685	CbGpPWpGaD
Pranlukast—MUC2—embryo—muscle cancer	0.0143	0.102	CbGeAlD
Pranlukast—IL5—Hematopoietic Stem Cell Differentiation—CSF3—muscle cancer	0.0122	0.05	CbGpPWpGaD
Pranlukast—RNASE3—tendon—muscle cancer	0.0121	0.0862	CbGeAlD
Pranlukast—RNASE3—bone marrow—muscle cancer	0.0118	0.0835	CbGeAlD
Pranlukast—MUC2—renal system—muscle cancer	0.0109	0.0771	CbGeAlD
Pranlukast—IL5—Regulation of nuclear SMAD2/3 signaling—TFE3—muscle cancer	0.0106	0.0435	CbGpPWpGaD
Pranlukast—IL5—testis—muscle cancer	0.00912	0.0648	CbGeAlD
Pranlukast—TNF—vagina—muscle cancer	0.00786	0.0559	CbGeAlD
Pranlukast—MUC2—head—muscle cancer	0.00726	0.0516	CbGeAlD
Pranlukast—MUC2—testis—muscle cancer	0.00701	0.0499	CbGeAlD
Pranlukast—MUC2—Metabolism of proteins—TIMM10—muscle cancer	0.00657	0.027	CbGpPWpGaD
Pranlukast—CYSLTR1—smooth muscle tissue—muscle cancer	0.00631	0.0449	CbGeAlD
Pranlukast—NFKB1—renal system—muscle cancer	0.00619	0.044	CbGeAlD
Pranlukast—NFKB1—TGF-beta Receptor Signaling—TFE3—muscle cancer	0.00595	0.0244	CbGpPWpGaD
Pranlukast—IL5—Regulation of nuclear SMAD2/3 signaling—MYOD1—muscle cancer	0.00582	0.0239	CbGpPWpGaD
Pranlukast—NFKB1—cardiac atrium—muscle cancer	0.00554	0.0394	CbGeAlD
Pranlukast—IL5—IL4-mediated signaling events—HMGA1—muscle cancer	0.00547	0.0225	CbGpPWpGaD
Pranlukast—TNF—Cytokines and Inflammatory Response—CSF3—muscle cancer	0.00516	0.0212	CbGpPWpGaD
Pranlukast—NFKB1—tendon—muscle cancer	0.00483	0.0343	CbGeAlD
Pranlukast—NFKB1—bone marrow—muscle cancer	0.00468	0.0333	CbGeAlD
Pranlukast—CYSLTR1—bone marrow—muscle cancer	0.0046	0.0327	CbGeAlD
Pranlukast—TNF—TGF-beta Receptor Signaling—TFE3—muscle cancer	0.00453	0.0186	CbGpPWpGaD
Pranlukast—NFKB1—vagina—muscle cancer	0.00448	0.0319	CbGeAlD
Pranlukast—CYSLTR1—vagina—muscle cancer	0.0044	0.0313	CbGeAlD
Pranlukast—NFKB1—Neural Crest Differentiation—PAX7—muscle cancer	0.00424	0.0174	CbGpPWpGaD
Pranlukast—NFKB1—Hair Follicle Development: Induction (Part 1 of 3)—TP63—muscle cancer	0.00422	0.0174	CbGpPWpGaD
Pranlukast—NFKB1—head—muscle cancer	0.00414	0.0294	CbGeAlD
Pranlukast—CYSLTR1—head—muscle cancer	0.00407	0.0289	CbGeAlD
Pranlukast—NFKB1—testis—muscle cancer	0.004	0.0284	CbGeAlD
Pranlukast—IL5—Regulation of nuclear SMAD2/3 signaling—FOXO4—muscle cancer	0.00396	0.0163	CbGpPWpGaD
Pranlukast—NFKB1—Angiopoietin receptor Tie2-mediated signaling—ANGPT2—muscle cancer	0.00391	0.0161	CbGpPWpGaD
Pranlukast—NFKB1—Neural Crest Differentiation—PAX3—muscle cancer	0.0036	0.0148	CbGpPWpGaD
Pranlukast—NFKB1—Hair Follicle Development: Induction (Part 1 of 3)—PTCH1—muscle cancer	0.00316	0.013	CbGpPWpGaD
Pranlukast—NFKB1—Rac1/Pak1/p38/MMP-2 pathway—ANGPT2—muscle cancer	0.00309	0.0127	CbGpPWpGaD
Pranlukast—NFKB1—BDNF signaling pathway—KIDINS220—muscle cancer	0.003	0.0123	CbGpPWpGaD
Pranlukast—TNF—Angiopoietin receptor Tie2-mediated signaling—ANGPT2—muscle cancer	0.00298	0.0122	CbGpPWpGaD
Pranlukast—IL5—Regulation of nuclear SMAD2/3 signaling—FOXO1—muscle cancer	0.00292	0.012	CbGpPWpGaD
Pranlukast—NFKB1—Apoptosis—TP73—muscle cancer	0.00282	0.0116	CbGpPWpGaD
Pranlukast—NFKB1—Melatonin metabolism and effects—FOXO1—muscle cancer	0.0027	0.0111	CbGpPWpGaD
Pranlukast—TNF—Transcription factor regulation in adipogenesis—FOXO1—muscle cancer	0.00257	0.0106	CbGpPWpGaD
Pranlukast—NFKB1—Regulation of Telomerase—WT1—muscle cancer	0.00253	0.0104	CbGpPWpGaD
Pranlukast—NFKB1—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—muscle cancer	0.00252	0.0103	CbGpPWpGaD
Pranlukast—IL5—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTGS2—muscle cancer	0.00249	0.0102	CbGpPWpGaD
Pranlukast—ABCC2—renal system—muscle cancer	0.00243	0.0173	CbGeAlD
Pranlukast—NFKB1—Apoptosis—TP63—muscle cancer	0.00243	0.00997	CbGpPWpGaD
Pranlukast—NFKB1—DNA Damage Response (only ATM dependent)—TP73—muscle cancer	0.00229	0.00941	CbGpPWpGaD
Pranlukast—NFKB1—Transcriptional regulation of white adipocyte differentiation—MED12—muscle cancer	0.00225	0.00927	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—TP73—muscle cancer	0.00215	0.00883	CbGpPWpGaD
Pranlukast—IL5—AP-1 transcription factor network—CDKN2A—muscle cancer	0.00203	0.00836	CbGpPWpGaD
Pranlukast—NFKB1—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—muscle cancer	0.00198	0.00815	CbGpPWpGaD
Pranlukast—NFKB1—Myometrial Relaxation and Contraction Pathways—CALD1—muscle cancer	0.00194	0.00797	CbGpPWpGaD
Pranlukast—ABCC2—tendon—muscle cancer	0.0019	0.0135	CbGeAlD
Pranlukast—NFKB1—AGE/RAGE pathway—FOXO4—muscle cancer	0.0019	0.00779	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—TP63—muscle cancer	0.00185	0.0076	CbGpPWpGaD
Pranlukast—ABCC2—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	0.00177	0.00729	CbGpPWpGaD
Pranlukast—NFKB1—Angiopoietin receptor Tie2-mediated signaling—FOXO1—muscle cancer	0.00175	0.00719	CbGpPWpGaD
Pranlukast—IL5—Glucocorticoid receptor regulatory network—MDM2—muscle cancer	0.00174	0.00714	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—KIDINS220—muscle cancer	0.00173	0.00712	CbGpPWpGaD
Pranlukast—NFKB1—SIDS Susceptibility Pathways—TP73—muscle cancer	0.00172	0.00707	CbGpPWpGaD
Pranlukast—TNF—Transcriptional regulation of white adipocyte differentiation—MED12—muscle cancer	0.00172	0.00706	CbGpPWpGaD
Pranlukast—TNF—Overview of nanoparticle effects—PTGS2—muscle cancer	0.00167	0.00687	CbGpPWpGaD
Pranlukast—ABCC2—testis—muscle cancer	0.00157	0.0112	CbGeAlD
Pranlukast—IL5—Hemostasis—ANGPT2—muscle cancer	0.00151	0.0062	CbGpPWpGaD
Pranlukast—IL5—Platelet activation, signaling and aggregation—IGF2—muscle cancer	0.00142	0.00585	CbGpPWpGaD
Pranlukast—NFKB1—AGE/RAGE pathway—FOXO1—muscle cancer	0.0014	0.00575	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—MYF6—muscle cancer	0.0014	0.00575	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—MYF5—muscle cancer	0.0014	0.00575	CbGpPWpGaD
Pranlukast—NFKB1—Rac1/Pak1/p38/MMP-2 pathway—FOXO1—muscle cancer	0.00138	0.00569	CbGpPWpGaD
Pranlukast—IL5—Allograft Rejection—VEGFA—muscle cancer	0.00136	0.00559	CbGpPWpGaD
Pranlukast—TNF—Angiopoietin receptor Tie2-mediated signaling—FOXO1—muscle cancer	0.00133	0.00547	CbGpPWpGaD
Pranlukast—TNF—SIDS Susceptibility Pathways—TP73—muscle cancer	0.00131	0.00538	CbGpPWpGaD
Pranlukast—NFKB1—Leptin signaling pathway—FOXO1—muscle cancer	0.00126	0.00519	CbGpPWpGaD
Pranlukast—NFKB1—Apoptosis—IGF2—muscle cancer	0.00125	0.00516	CbGpPWpGaD
Pranlukast—CYP3A4—renal system—muscle cancer	0.00123	0.00877	CbGeAlD
Pranlukast—IL5—AP-1 transcription factor network—TP53—muscle cancer	0.00113	0.00465	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—WT1—muscle cancer	0.00111	0.00455	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—CNR1—muscle cancer	0.0011	0.00454	CbGpPWpGaD
Pranlukast—MUC2—Metabolism of proteins—IGF2—muscle cancer	0.00108	0.00444	CbGpPWpGaD
Pranlukast—NFKB1—Aryl Hydrocarbon Receptor—PTGS2—muscle cancer	0.00108	0.00444	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—MYF6—muscle cancer	0.00107	0.00438	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—MYF5—muscle cancer	0.00107	0.00438	CbGpPWpGaD
Pranlukast—NFKB1—B Cell Receptor Signaling Pathway—FOXO1—muscle cancer	0.00103	0.00423	CbGpPWpGaD
Pranlukast—IL5—Glucocorticoid receptor regulatory network—TP53—muscle cancer	0.000997	0.0041	CbGpPWpGaD
Pranlukast—NFKB1—BDNF signaling pathway—CNR1—muscle cancer	0.000997	0.0041	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—IGF2—muscle cancer	0.000955	0.00393	CbGpPWpGaD
Pranlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—CNR1—muscle cancer	0.000946	0.00389	CbGpPWpGaD
Pranlukast—TNF—Adipogenesis—HMGA1—muscle cancer	0.000936	0.00385	CbGpPWpGaD
Pranlukast—NFKB1—Cellular Senescence—HMGA1—muscle cancer	0.000922	0.00379	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—KIDINS220—muscle cancer	0.000916	0.00376	CbGpPWpGaD
Pranlukast—NFKB1—Downstream signaling events of B Cell Receptor (BCR)—FOXO4—muscle cancer	0.000902	0.00371	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—MYOG—muscle cancer	0.000902	0.00371	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—FOXO4—muscle cancer	0.000861	0.00354	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR ligand binding—PTCH1—muscle cancer	0.000853	0.00351	CbGpPWpGaD
Pranlukast—NFKB1—Aryl Hydrocarbon Receptor—VEGFA—muscle cancer	0.000851	0.0035	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—WT1—muscle cancer	0.000844	0.00347	CbGpPWpGaD
Pranlukast—TNF—Aryl Hydrocarbon Receptor—PTGS2—muscle cancer	0.000824	0.00339	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—BUB1B—muscle cancer	0.00081	0.00333	CbGpPWpGaD
Pranlukast—NFKB1—B Cell Activation—FOXO4—muscle cancer	0.000797	0.00328	CbGpPWpGaD
Pranlukast—CYP2C9—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	0.000779	0.0032	CbGpPWpGaD
Pranlukast—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTGS2—muscle cancer	0.00077	0.00317	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—IGF2—muscle cancer	0.000734	0.00302	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Breast Cancer Pathway—FOXO1—muscle cancer	0.000722	0.00297	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR ligand binding—CNR1—muscle cancer	0.00072	0.00296	CbGpPWpGaD
Pranlukast—NFKB1—Apoptosis—CDKN2A—muscle cancer	0.000714	0.00294	CbGpPWpGaD
Pranlukast—NFKB1—Glucocorticoid receptor regulatory network—MDM2—muscle cancer	0.000706	0.0029	CbGpPWpGaD
Pranlukast—IL5—Immune System—CD34—muscle cancer	0.000705	0.0029	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—HMGA1—muscle cancer	0.000697	0.00287	CbGpPWpGaD
Pranlukast—NFKB1—Apoptosis—MDM2—muscle cancer	0.000693	0.00285	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—MYOG—muscle cancer	0.000687	0.00282	CbGpPWpGaD
Pranlukast—NFKB1—Apoptosis Modulation and Signaling—CDKN2A—muscle cancer	0.00067	0.00275	CbGpPWpGaD
Pranlukast—NFKB1—Downstream signaling events of B Cell Receptor (BCR)—FOXO1—muscle cancer	0.000666	0.00274	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—KIDINS220—muscle cancer	0.000657	0.0027	CbGpPWpGaD
Pranlukast—TNF—Aryl Hydrocarbon Receptor—VEGFA—muscle cancer	0.000649	0.00267	CbGpPWpGaD
Pranlukast—NFKB1—Oncostatin M Signaling Pathway—VEGFA—muscle cancer	0.000646	0.00265	CbGpPWpGaD
Pranlukast—NFKB1—Selenium Micronutrient Network—PTGS2—muscle cancer	0.000643	0.00264	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—FOXO1—muscle cancer	0.000636	0.00261	CbGpPWpGaD
Pranlukast—TNF—Adipogenesis—FOXO1—muscle cancer	0.00062	0.00255	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—BUB1B—muscle cancer	0.000617	0.00254	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—PTCH1—muscle cancer	0.00061	0.00251	CbGpPWpGaD
Pranlukast—NFKB1—Senescence-Associated Secretory Phenotype (SASP)—CDKN2A—muscle cancer	0.000597	0.00246	CbGpPWpGaD
Pranlukast—IL5—Platelet activation, signaling and aggregation—VEGFA—muscle cancer	0.000597	0.00245	CbGpPWpGaD
Pranlukast—NFKB1—B Cell Activation—FOXO1—muscle cancer	0.000588	0.00242	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—FOXO4—muscle cancer	0.000586	0.00241	CbGpPWpGaD
Pranlukast—NFKB1—DNA Damage Response (only ATM dependent)—CDKN2A—muscle cancer	0.00058	0.00238	CbGpPWpGaD
Pranlukast—TNF—Amyotrophic lateral sclerosis (ALS)—TP53—muscle cancer	0.000571	0.00235	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—CNR1—muscle cancer	0.000567	0.00233	CbGpPWpGaD
Pranlukast—NFKB1—DNA Damage Response (only ATM dependent)—MDM2—muscle cancer	0.000562	0.00231	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—MYOD1—muscle cancer	0.000557	0.00229	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—CDKN2A—muscle cancer	0.000544	0.00224	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—MDM2—muscle cancer	0.000528	0.00217	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—CNR1—muscle cancer	0.000515	0.00212	CbGpPWpGaD
Pranlukast—CYP3A4—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	0.000514	0.00211	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—MED12—muscle cancer	0.00051	0.00209	CbGpPWpGaD
Pranlukast—NFKB1—Downstream signaling events of B Cell Receptor (BCR)—KIT—muscle cancer	0.000508	0.00209	CbGpPWpGaD
Pranlukast—TNF—Selenium Micronutrient Network—PTGS2—muscle cancer	0.00049	0.00201	CbGpPWpGaD
Pranlukast—NFKB1—Oncostatin M Signaling Pathway—TP53—muscle cancer	0.000488	0.00201	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—KIT—muscle cancer	0.000484	0.00199	CbGpPWpGaD
Pranlukast—NFKB1—Folate Metabolism—TP53—muscle cancer	0.000482	0.00198	CbGpPWpGaD
Pranlukast—IL5—Immune System—FOXO4—muscle cancer	0.000479	0.00197	CbGpPWpGaD
Pranlukast—NFKB1—Rac1/Pak1/p38/MMP-2 pathway—TP53—muscle cancer	0.000476	0.00196	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—CD34—muscle cancer	0.000473	0.00194	CbGpPWpGaD
Pranlukast—NFKB1—B Cell Activation—KIT—muscle cancer	0.000448	0.00184	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—PTCH1—muscle cancer	0.000438	0.0018	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Breast Cancer Pathway—MDM2—muscle cancer	0.000433	0.00178	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—FOXO1—muscle cancer	0.000433	0.00178	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—MYOD1—muscle cancer	0.000424	0.00175	CbGpPWpGaD
Pranlukast—TNF—Allograft Rejection—VEGFA—muscle cancer	0.000421	0.00173	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—CNR1—muscle cancer	0.000407	0.00167	CbGpPWpGaD
Pranlukast—NFKB1—Glucocorticoid receptor regulatory network—TP53—muscle cancer	0.000405	0.00167	CbGpPWpGaD
Pranlukast—NFKB1—Downstream signaling events of B Cell Receptor (BCR)—MDM2—muscle cancer	0.0004	0.00164	CbGpPWpGaD
Pranlukast—NFKB1—Apoptosis—TP53—muscle cancer	0.000397	0.00163	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—MED12—muscle cancer	0.000388	0.0016	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—PTGS2—muscle cancer	0.000388	0.00159	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—MDM2—muscle cancer	0.000382	0.00157	CbGpPWpGaD
Pranlukast—NFKB1—Cellular Senescence—CDKN2A—muscle cancer	0.000378	0.00155	CbGpPWpGaD
Pranlukast—NFKB1—Apoptosis Modulation and Signaling—TP53—muscle cancer	0.000373	0.00153	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—KIDINS220—muscle cancer	0.000372	0.00153	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—CNR1—muscle cancer	0.00037	0.00152	CbGpPWpGaD
Pranlukast—TNF—Folate Metabolism—TP53—muscle cancer	0.000367	0.00151	CbGpPWpGaD
Pranlukast—NFKB1—Cellular Senescence—MDM2—muscle cancer	0.000367	0.00151	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—PTCH1—muscle cancer	0.00036	0.00148	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—MDM2—muscle cancer	0.000359	0.00148	CbGpPWpGaD
Pranlukast—IL5—Immune System—FOXO1—muscle cancer	0.000354	0.00146	CbGpPWpGaD
Pranlukast—NFKB1—B Cell Activation—MDM2—muscle cancer	0.000353	0.00145	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—PTGS2—muscle cancer	0.000346	0.00142	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—FOXO4—muscle cancer	0.000334	0.00137	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—KIT—muscle cancer	0.00033	0.00136	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Breast Cancer Pathway—VEGFA—muscle cancer	0.000329	0.00135	CbGpPWpGaD
Pranlukast—NFKB1—DNA Damage Response (only ATM dependent)—TP53—muscle cancer	0.000323	0.00133	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—FOXO4—muscle cancer	0.000321	0.00132	CbGpPWpGaD
Pranlukast—NFKB1—SIDS Susceptibility Pathways—VEGFA—muscle cancer	0.000321	0.00132	CbGpPWpGaD
Pranlukast—TNF—Alzheimers Disease—TP53—muscle cancer	0.000318	0.00131	CbGpPWpGaD
Pranlukast—CYP2C9—Arachidonic acid metabolism—PTGS2—muscle cancer	0.000316	0.0013	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—FOXO4—muscle cancer	0.00031	0.00127	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—VEGFA—muscle cancer	0.000308	0.00126	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—CNR1—muscle cancer	0.000304	0.00125	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—TP53—muscle cancer	0.000303	0.00124	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CD34—muscle cancer	0.000287	0.00118	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—CDKN2A—muscle cancer	0.000286	0.00117	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—FOXO1—muscle cancer	0.00028	0.00115	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—MDM2—muscle cancer	0.000277	0.00114	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—MDM2—muscle cancer	0.000274	0.00112	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	0.000273	0.00112	CbGpPWpGaD
Pranlukast—IL5—Immune System—KIT—muscle cancer	0.00027	0.00111	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—PTGS2—muscle cancer	0.000264	0.00108	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—MDM2—muscle cancer	0.00026	0.00107	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—PTCH1—muscle cancer	0.000259	0.00106	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—IGF2—muscle cancer	0.000249	0.00102	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Breast Cancer Pathway—TP53—muscle cancer	0.000249	0.00102	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—FOXO1—muscle cancer	0.000247	0.00102	CbGpPWpGaD
Pranlukast—TNF—SIDS Susceptibility Pathways—VEGFA—muscle cancer	0.000244	0.001	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—FOXO1—muscle cancer	0.000237	0.000975	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—TP53—muscle cancer	0.000232	0.000956	CbGpPWpGaD
Pranlukast—CYP3A4—Tryptophan metabolism—MDM2—muscle cancer	0.000231	0.000949	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—TP53—muscle cancer	0.000231	0.000948	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—FOXO1—muscle cancer	0.000229	0.000941	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—TP53—muscle cancer	0.000228	0.000938	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—FOXO4—muscle cancer	0.000222	0.000914	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CNR1—muscle cancer	0.000218	0.000898	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—FOXO1—muscle cancer	0.000213	0.000876	CbGpPWpGaD
Pranlukast—IL5—Immune System—MDM2—muscle cancer	0.000212	0.000873	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—VEGFA—muscle cancer	0.00021	0.000865	CbGpPWpGaD
Pranlukast—NFKB1—Cellular Senescence—TP53—muscle cancer	0.00021	0.000865	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	0.000208	0.000854	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	0.000206	0.000847	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—FOXO4—muscle cancer	0.000195	0.000801	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—KIT—muscle cancer	0.000188	0.000774	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—TP53—muscle cancer	0.000185	0.000762	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—KIT—muscle cancer	0.000181	0.000743	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—IGF2—muscle cancer	0.000179	0.000734	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—KIT—muscle cancer	0.000174	0.000717	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—TP53—muscle cancer	0.000174	0.000715	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—FOXO1—muscle cancer	0.000164	0.000675	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—TP53—muscle cancer	0.000159	0.000654	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	0.000157	0.000645	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—MDM2—muscle cancer	0.000148	0.000609	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—PTCH1—muscle cancer	0.000146	0.000602	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—FOXO1—muscle cancer	0.000144	0.000591	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—MDM2—muscle cancer	0.000142	0.000585	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—MED12—muscle cancer	0.000142	0.000584	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—MDM2—muscle cancer	0.000137	0.000565	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—VEGFA—muscle cancer	0.000127	0.000524	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—FOXO4—muscle cancer	0.000126	0.000518	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—KIT—muscle cancer	0.000125	0.000515	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CNR1—muscle cancer	0.000124	0.000508	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—FH—muscle cancer	0.000112	0.00046	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—KIT—muscle cancer	0.00011	0.000451	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—VEGFA—muscle cancer	0.000104	0.000429	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—IGF2—muscle cancer	0.000101	0.000416	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—MDM2—muscle cancer	9.86e-05	0.000405	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—VEGFA—muscle cancer	9.71e-05	0.000399	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—FOXO1—muscle cancer	9.3e-05	0.000382	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—MDM2—muscle cancer	8.63e-05	0.000355	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—TP53—muscle cancer	7.88e-05	0.000324	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—VEGFA—muscle cancer	7.49e-05	0.000308	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—FH—muscle cancer	7.38e-05	0.000303	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—KIT—muscle cancer	7.09e-05	0.000291	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—MED12—muscle cancer	6.32e-05	0.00026	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—ENO2—muscle cancer	5.77e-05	0.000237	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—TP53—muscle cancer	5.66e-05	0.000233	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—MDM2—muscle cancer	5.58e-05	0.000229	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	4.51e-05	0.000185	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—VEGFA—muscle cancer	4.24e-05	0.000174	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—MED12—muscle cancer	4.17e-05	0.000171	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—ENO2—muscle cancer	3.8e-05	0.000156	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—TP53—muscle cancer	3.2e-05	0.000132	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PTGS2—muscle cancer	2.01e-05	8.26e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PTGS2—muscle cancer	1.32e-05	5.44e-05	CbGpPWpGaD
